P420: Correlation between Infliximab trough levels and endoscopic activity in ulcerative colitis
ECCO '19 Copenhagen
2019
P421: Effects of combination therapy in inflammatory bowel disease: how long should we keep concomitant immunomodulators?
ECCO '19 Copenhagen
2019
P422: Immunogenicity of a proposed adalimumab biosimilar, FKB327, and the reference product in patients with rheumatoid arthritis
ECCO '19 Copenhagen
2019
P423: Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis
ECCO '19 Copenhagen
2019
P424: Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multi-centre cohort study of the ENEIDA registry
ECCO '19 Copenhagen
2019
P425: Development of an enzyme-linked immunosorbent assay for therapeutic drug monitoring of ustekinumab
ECCO '19 Copenhagen
2019
P426: Lympocytosis in patients with inflammatory bowel disease treated with anti-TNFa agents: is it significant?
ECCO '19 Copenhagen
2019
P427: Impact of curcuma longa on clinical activity and inflammatory markers in patients with active ulcerative colitis: a double-blind randomised placebo-controlled trial
ECCO '19 Copenhagen
2019
P428: Long-term outcomes of endoscopic ballon dilation for small-bowl strictures using double balloon enteroscopy in patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P429: Factors associated with weight gain in patients treated with anti-TNF-α for inflammatory bowel disease: a cohort study
ECCO '19 Copenhagen
2019
P431: Validation of a therapeutic drug monitoring test to measure the adalimumab biosimilar SB5 in comparison with the reference adalimumab
ECCO '19 Copenhagen
2019
P432: Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the ‘EXPLORE’ study
ECCO '19 Copenhagen
2019
P433: Aetiologies of iron deficiency-related anaemia in German patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P435: Rapidity of symptomatic and inflammatory biomarker improvements following upadacitinib induction treatment: data from the U-ACHIEVE study
ECCO '19 Copenhagen
2019
P436: Darvadstrocel treatment outcomes in Crohn’s disease patients with complex perianal fistulas: the role of TNFi co-treatment in ADMIRE CD
ECCO '19 Copenhagen
2019